Advertisement

Advertisement

CTXR Stock Latest News

Citius Pharmaceuticals Receives Nasdaq Extension to Regain Compliance

Company AnnouncementsCitius Pharmaceuticals Receives Nasdaq Extension to Regain Compliance

Is CTXR a Buy, Before Earnings?

PremiumPre-Earnings

Is CTXR a Buy, Before Earnings?

2M ago

Citius Oncology reports strong LYMPHIR U.S. launch momentum

PremiumCompany Announcements

Citius Oncology reports strong LYMPHIR U.S. launch momentum

2M ago

Citius Oncology reports availability of Lymphir in institutions grew 78% in Q3

PremiumThe Fly

Citius Oncology reports availability of Lymphir in institutions grew 78% in Q3

2M ago

Citius Oncology provides update on commercial launch of Lymphir

PremiumThe Fly

Citius Oncology provides update on commercial launch of Lymphir

2M ago

Citius Highlights LYMPHIR Combo Data in Gynecologic Cancers

PremiumCompany AnnouncementsCitius Highlights LYMPHIR Combo Data in Gynecologic Cancers

4M ago

Citius Oncology highlights Phase 1 data evaluating Lymphir at ASCO

The Fly

Citius Oncology highlights Phase 1 data evaluating Lymphir at ASCO

4M ago

CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts

Weekend Updates

CTXR, AMT, JAZZ, CTMX, FATE Trending With Analysts

4M ago

Citius Pharmaceuticals files to sell 5.43M shares of common stock for holders

PremiumThe Fly

Citius Pharmaceuticals files to sell 5.43M shares of common stock for holders

4M ago

Citius Pharmaceuticals assumed with a Buy at H.C. Wainwright

PremiumThe Fly

Citius Pharmaceuticals assumed with a Buy at H.C. Wainwright

5M ago

Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility

PremiumCompany Announcements

Citius Pharmaceuticals Amends Promissory Note to Enhance Flexibility

5M ago

Citius Expands LYMPHIR Access with First European Shipment

PremiumCompany Announcements

Citius Expands LYMPHIR Access with First European Shipment

5M ago

Citius Oncology announces initial shipment of LYMPHIR to Europe

PremiumThe FlyCitius Oncology announces initial shipment of LYMPHIR to Europe

5M ago

Citius Pharmaceuticals Raises $5 Million in Securities Offering

Company Announcements

Citius Pharmaceuticals Raises $5 Million in Securities Offering

5M ago

Citius Pharmaceuticals announces $5M registered direct offering priced ATM

The Fly

Citius Pharmaceuticals announces $5M registered direct offering priced ATM

5M ago

Citius Pharmaceuticals Announces 2026 Annual Stockholder Meeting Results

PremiumCompany Announcements

Citius Pharmaceuticals Announces 2026 Annual Stockholder Meeting Results

6M ago

Citius Oncology advances LYMPHIR launch and global expansion

PremiumCompany Announcements

Citius Oncology advances LYMPHIR launch and global expansion

6M ago

Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data

PremiumCompany Announcements

Citius Highlights Positive LYMPHIR Phase 1 Gynecologic Cancer Data

7M ago

Citius Oncology Reports Positive LYMPHIR Phase 1 CAR-T Data

PremiumCompany Announcements

Citius Oncology Reports Positive LYMPHIR Phase 1 CAR-T Data

7M ago

Citius Pharmaceuticals receives $3.8M through NJEDA program

PremiumThe FlyCitius Pharmaceuticals receives $3.8M through NJEDA program

7M ago

Citius Pharmaceuticals Posts First Revenue Amid Listing Risk

Company Announcements

Citius Pharmaceuticals Posts First Revenue Amid Listing Risk

8M ago

Citius Oncology reports Q1 EPS (6c) vs. (9c) last year

The Fly

Citius Oncology reports Q1 EPS (6c) vs. (9c) last year

8M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >